Two bioscience-related firms are securing investments and helping to boost Arizona’s venture capital to its best figure in three years.
Arizona’s third quarter venture capital total is $50.5 million, compared with $69.6 million last year, according to the MoneyTree Survey released by Pricewaterhouse Coopers, Thomson Venture Economics, and the National Venture Capital Association.
The bioscience-related companies funded during the quarter, according to MoneyTree, include:
- Carefx Corp. of Scottsdale, $11.5 million. It was the third round of funding for the developer of health care software.
- APT Pharmaceuticals of Tucson, $6 million. It was the first round for the biotech company.
Venture capital investments have topped $123 million through the first nine months of this year.
For more information:
Bio firms help Arizona to VC high, 07/27/2005
“Venture funds tops in 3 years,” Arizona Republic, 10/25/2005